Skip to content

Peri-articular injection for Pain Relief After Anterior Cruciate Ligament Reconstruction

Peri-articular injection of Ropivacaine and Morphine Versus Ropivacaine for Pain Relief After Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
CRIS
Registry ID
KCT0003572
Enrollment
34
Registered
2019-02-28
Start date
2019-01-31
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : This study is a prospective study. Subjects who agreed to voluntarily participate in the study and signed the consent form are randomly assigned to one of the two groups at a ratio of 1 : 1 . R

Sponsors

Chung-Ang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients from 19 to 60 years of age who underwent primary anterior cruciate ligament reconstruction at Chung-Ang University Hospital and can cooperate in collecting data

Exclusion criteria

Exclusion criteria: Patients with an American Society of Anesthesiologist grade 3 or higher A previous history of previous knee surgery or reconstruction of other ligaments Patients who underwent autogenous reconstruction of the anterior cruciate ligament, re-reconstruction of anterior cruciate ligament, or concomitant high tibial osteotomy Patients who have allergies or contraindications of medication used in this study for pain control and those who do not consent to use Patients who are constantly using analgesics regardless of the study Patients who have serious cardiovascular, kidney disease, hematologic abnormalities, obesity (BMI> 35)

Design outcomes

Primary

MeasureTime frame
Visual analog scale

Secondary

MeasureTime frame
pain VAS score (Visual analog scale);use of rescue medication,;side effects;patient satisfaction with pain control

Countries

Korea, Republic of

Contacts

Public ContactYong-Beom Park

Chung-Ang Univerisity Hospital

whybe1122@gmail.com+82-2-6299-1577

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026